Literature DB >> 20167872

Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells.

Yasuhiro Suzuki1, Xisheng Wang, Benard S Jortner, Laura Payne, Yanyan Ni, Sara A Michie, Baohui Xu, Tomoya Kudo, Sara Perkins.   

Abstract

Chronic infection with Toxoplasma gondii is one of the most common parasitic infections in humans. Formation of tissue cysts is the basis of persistence of the parasite in infected hosts, and this cyst stage has generally been regarded as untouchable. Here we provide the first evidence that the immune system can eliminate T. gondii cysts from the brains of infected hosts when immune T cells are transferred into infected immunodeficient animals that have already developed large numbers of cysts. This T cell-mediated immune process was associated with accumulation of microglia and macrophages around tissue cysts. CD8(+) immune T cells possess a potent activity to remove the cysts. The initiation of this process by CD8(+) T cells does not require their production of interferon-gamma, the major mediator to prevent proliferation of tachyzoites during acute infection, but does require perforin. These results suggest that CD8(+) T cells induce elimination of T. gondii cysts through their perforin-mediated cytotoxic activity. Our findings provide a new mechanism of the immune system to fight against chronic infection with T. gondii and suggest a possibility of developing a novel vaccine to eliminate cysts from patients with chronic infection and to prevent the establishment of chronic infection after a newly acquired infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167872      PMCID: PMC2843452          DOI: 10.2353/ajpath.2010.090825

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Cryptogenic epilepsy: an infectious etiology?

Authors:  E W Stommel; R Seguin; V M Thadani; J D Schwartzman; K Gilbert; K A Ryan; T D Tosteson; L H Kasper
Journal:  Epilepsia       Date:  2001-03       Impact factor: 5.864

2.  In vitro cultivation of Toxoplasma gondii cysts in astrocytes in the presence of gamma interferon.

Authors:  T C Jones; K A Bienz; P Erb
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  An ultrastructural study of the early development and tissue cyst formation of Toxoplasma gondii in the brains of mice.

Authors:  D J Ferguson; W M Hutchison
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

4.  Fine structure of Toxoplasma in the human brain.

Authors:  N R Ghatak; H M Zimmerman
Journal:  Arch Pathol       Date:  1973-04

5.  HLA-class II genes modify outcome of Toxoplasma gondii infection.

Authors:  D G Mack; J J Johnson; F Roberts; C W Roberts; R G Estes; C David; F C Grumet; R McLeod
Journal:  Int J Parasitol       Date:  1999-09       Impact factor: 3.981

6.  Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease.

Authors:  Xisheng Wang; Hoil Kang; Takane Kikuchi; Yasuhiro Suzuki
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Investigation of probable relationship between Toxoplasma gondii and cryptogenic epilepsy.

Authors:  Süleyman Yazar; Fehim Arman; Saban Yalçin; Funda Demirtaş; Ozan Yaman; Izzet Sahin
Journal:  Seizure       Date:  2003-03       Impact factor: 3.184

8.  Toxoplasma gondii infection of the central nervous system. Use of the peroxidase-antiperoxidase method to demonstrate toxoplasma in formalin fixed, paraffin embedded tissue sections.

Authors:  F K Conley; K A Jenkins; J S Remington
Journal:  Hum Pathol       Date:  1981-08       Impact factor: 3.466

9.  Dynamic imaging of T cell-parasite interactions in the brains of mice chronically infected with Toxoplasma gondii.

Authors:  Marie Schaeffer; Seong-Ji Han; Tatyana Chtanova; Giel G van Dooren; Paul Herzmark; Ying Chen; Badrinath Roysam; Boris Striepen; Ellen A Robey
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

10.  Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.

Authors:  Y Suzuki; M A Orellana; R D Schreiber; J S Remington
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

View more
  56 in total

1.  Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.

Authors:  Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Rima McLeod
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

2.  PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection.

Authors:  Rajarshi Bhadra; Jason P Gigley; Imtiaz A Khan
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

Review 3.  Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.

Authors:  Yasuhiro Suzuki; Qila Sa; Marie Gehman; Eri Ochiai
Journal:  Expert Rev Mol Med       Date:  2011-10-04       Impact factor: 5.600

Review 4.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

5.  Toxoplasma: Immunity and Pathogenesis.

Authors:  Imtiaz A Khan; Charlotte Ouellette; Keer Chen; Magali Moretto
Journal:  Curr Clin Microbiol Rep       Date:  2019-02-04

6.  VCAM-1/α4β1 integrin interaction is crucial for prompt recruitment of immune T cells into the brain during the early stage of reactivation of chronic infection with Toxoplasma gondii to prevent toxoplasmic encephalitis.

Authors:  Qila Sa; Eri Ochiai; Tomoko Sengoku; Melinda E Wilson; Morgan Brogli; Stephen Crutcher; Sara A Michie; Baohui Xu; Laura Payne; Xisheng Wang; Yasuhiro Suzuki
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

Review 7.  A review on inactivation methods of Toxoplasma gondii in foods.

Authors:  Adel Mirza Alizadeh; Sahar Jazaeri; Bahar Shemshadi; Fataneh Hashempour-Baltork; Zahra Sarlak; Zahra Pilevar; Hedayat Hosseini
Journal:  Pathog Glob Health       Date:  2018-10-22       Impact factor: 2.894

8.  Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of Toxoplasma gondii.

Authors:  Qila Sa; Eri Ochiai; Ashish Tiwari; Jeremi Mullins; Nilabh Shastri; Corinne Mercier; Marie-France Cesbron-Delauw; Yasuhiro Suzuki
Journal:  J Immunol       Date:  2017-04-26       Impact factor: 5.422

9.  A Bradyzoite is a Bradyzoite is a Bradyzoite?

Authors:  Kami Kim
Journal:  Trends Parasitol       Date:  2015-10-26

Review 10.  The immune system utilizes two distinct effector mechanisms of T cells depending on two different life cycle stages of a single pathogen, Toxoplasma gondii, to control its cerebral infection.

Authors:  Yasuhiro Suzuki
Journal:  Parasitol Int       Date:  2019-11-25       Impact factor: 2.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.